AMT enters agreement with Consortium for clinical development of novel gene therapy to take care of Sanfilippo B Amsterdam Molecular Therapeutics , a innovator in individual gene therapy, today that it has entered into an agreement with Institut Pasteur announced, Paris, France, and a group of French research institutes to aid clinical advancement of a novel gene therapy to take care of Sanfilippo B. This rare genetic disease affecting new-born children prospects to progressive neuronal death and degeneration. There is no approved therapy available presently azithromycin tablets 500 mg . On behalf of the Consortium, Institut Pasteur will business lead the development system and can also sponsor the initial Phase I/II medical research of a gene therapy to replace an enzyme that’s missing in human brain cells of SanfilippoB patients.
That is why we anticipate that the earn-out portion of the transaction may generate significant returns for AMS over the next few years, said AMS Chairman and CEO Ernest A. Bates, M.D.. AMS agrees to market Gamma Knife and radiation therapy providers business in Turkey to Euromedic AMERICAN SHARED HOSPITAL Providers , a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that it has entered into an agreement to sell its Gamma Knife and radiation therapy services business in Turkey to Euromedic Cancer tumor Treatment Centers BV .